The Indo-Finland initiative will be developing an affordable medical point of care diagnostics device for use in India and other developing countries
Labsystems Diagnostics OY, a Trivitron Healthcare Enterprise has signed a MOU at Helsinki in the presence of President of India, Pranab Mukherjee along with The University of Turku, and Indian Translational Health Science Technology Institute (THSTI). This Indo-Finland initiative will be developing an affordable medical point of care diagnostics device for use in India and other developing countries. This diagnostic platform can reportedly be used for testing cardiac troponin-I for acute coronary syndrome and for high sensitive detection of several other parameters like infectious diseases, cancer markers, new born screening panel etc. The research was funded by Indian Department of Biotechnology under the Ministry of Science and Technology, Tekes (the Finnish Funding Agency for Innovation) and the Academy of Finland.
The kits for these UCP-based platform will be produced in Labsystems Finland and in the upcoming new facility in Trivitron Medical Technology Park in Chennai.
Says Dr GSK Velu, Founder & MD, Trivitron Healthcare,“We are proud to announce the signing of this MOU in the presence of President Pranab Mukherjee and joint motive to promote ‘Make in India’. Trivitron Healthcare and the partners signing the MoU wish to promote, deepen and widen short- and long-term academic and commercial cooperation in research and development between Indian and Finnish medical technology players in the field of in vitro diagnostics. This MOU will go a long way in contributing to Trivitron Healthcare’s vision of making healthcare affordable and accessible to everyone across the globe.”
Trivitron Healthcare also signed a MoU with The University of Turku on the same day to manifest their intentions to jointly promote academic training and research in Finland and India within the field of in vitro diagnostics along with establishment of skill development institute in India. Through close collaboration in translational research and development, the partners seek to develop unique expertise for the design of novel, simple and affordable diagnostic tests and test platforms to the global market. This will be achieved by encouraging exchange of researchers as well as recruitment of students to the international master’s degree and doctoral programmes of the University of Turku.
A third memorandum was also signed between Trivitron Healthcare, Planmeca OY and Nordic Institute of Dental Education. A company release informs that the purpose of the MoU is to enhance business and educational cooperation between Planmeca, NIDE and Trivitron and to expand the offering of dental technology and knowhow in India by running skill development courses in India to the dental community.
EH News Bureau